Surgical management of BPH in patients on oral anticoagulation: Transurethral bipolar plasma vaporization in saline versus transurethral monopolar resection of the prostate

Canadian Journal of Urology

Volumn 18, Issue 6, 2011, Pages 6007-6012

  Delongchamps, Nicolas B ^a   Robert, Grégoire ^b   de la Taille, Alexandre ^c   Haillot, Olivier ^d   Ballereau, Charles ^e   Saussine, Christian ^f   Kleinclauss, François ^g   Azzouzi, Abdel Rahmène ^h   Lukacs, Bertrand ⁱ   Dumonceau, Olivier ^j   Fourmarier, Marc ^k   Devonec, Marian ^l   Descazeaud, Aurélien ^m  

^a Institut Cochin   (France)

^b HÔPITAL PELLEGRIN   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e La Louvière Hospital   (France)

^f UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^g UNIVERSITY HOSPITAL OF BESANÇON   (France)

^h ANGERS UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL TENON   (France)

^j SAINT JOSEPH HOSPITAL   (France)

^k CENTRE HOSPITALIER DU PAYS D AIX   (France)

^l HOSPICES CIVILS DE LYON   (France)

^m LIMOGES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Benign prostatic hyperplasia; Plasma vaporization; TURP; TUVIS

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ARTICLE; BLADDER CATHETERIZATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; HEMATURIA; HUMAN; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE HEMORRHAGE; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; VOLATILIZATION;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINARY CATHETERIZATION; VOLATILIZATION;

EID: 84860234389     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Madersbacher S, Lackner J, Brössner C et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 2005;47(4):499-504.
2. Lebdai S, Robert G, Devonnec M et al. Management of patients under anticoagulants for transurethral resection of the prostate: a multicentric study by the CTMH-AFU. Prog Urol 2009;19(8):553-557.
3. Hon NH, Brathwaite D, Hussain Z et al. A prospective, randomized trial comparing conventional transurethral prostate resection with PlasmaKinetic vaporization of the prostate: physiological changes, early complications and long-term followup. J Urol 2006;176(1):205-209.
4. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336(21):1506-1511.
5. Hoffman RM, MacDonald R, Wilt TJ. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev 2004(1):CD001987.
6. Ruszat R, Wyler S, Forster T et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007;51(4):1031-1038.
7. Chakravarti A, MacDermott S. Transurethral resection of the prostate in the anticoagulated patient. BJU Int 1998;81(4):520-522.
8. Dotan ZA, Mor Y, Leibovitch I et al. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 2002;168(2):610-613.
9. Parr NJ, Loh CS, Desmond AD. Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol 1989;64(6):623-625.
10. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 2005;257(5):399-414.
11. Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy-a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 2000;34(3):194-198.
12. Ehrlich Y, Yossepowitch O, Margel D, Lask D, Livne PM, Baniel J. Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial. J Urol 2007;178(2):524-528.
13. Lourenco T, Armstrong N, N'Dow J et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 2008;12(35):1-146.
14. Ruszat R, Wyler SF, Seitz M et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008;102(10):1432-1438.
15. Elzayat E, Habib E, Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol 2006;175(4):1428-1432.
16. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol 2006;50(5):969-979.
17. Dunsmuir WD, McFarlane JP, Tan A et al. Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate Cancer Prostatic Dis 2003;6(2):182-186.